Nuveen’s ProKidney PROK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$207K Buy
+101,461
New +$186K ﹤0.01% 3632
2025
Q2
Sell
-266,366
Closed -$233K 3377
2025
Q1
$233K Hold
266,366
﹤0.01% 3091
2024
Q4
$450K Buy
266,366
+39,216
+17% +$70.7K ﹤0.01% 3018
2024
Q3
$436K Sell
227,150
-60,879
-21% -$138K ﹤0.01% 3054
2024
Q2
$709K Buy
288,029
+152,199
+112% +$409K ﹤0.01% 2872
2024
Q1
$223K Hold
135,830
﹤0.01% 3164
2023
Q4
$242K Sell
135,830
-17,330
-11% -$37.2K ﹤0.01% 3183
2023
Q3
$701K Sell
153,160
-57,732
-27% -$553K ﹤0.01% 2719
2023
Q2
$2.36M Buy
+210,892
New +$2.24M ﹤0.01% 2271

Other funds holding PROK

Nuveen's PROK Position: Q2 2026 in Review

Nuveen opened a new position in ProKidney (PROK) in Q2 2026: 101,461 shares worth $207K. The stake represents ﹤0.01% of the portfolio and ranks #3632 among its holdings. This is a return to the name: Nuveen previously reported a position in PROK as recently as Q1 2025.

Nuveen first reported a position in PROK in Q2 2023 and has held it in 9 quarters since. The position peaked at $2.36M in Q2 2023. 71 funds tracked by Wall St. Rank hold PROK as of Q2 2026.

  • Nuveen held 101,461 shares of ProKidney worth $207K as of Q2 2026.
  • ProKidney was a new Nuveen position in Q2 2026.
  • ProKidney made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #3632 holding.
  • Nuveen first reported a position in ProKidney in Q2 2023 and has held it in 9 quarters since.
  • Nuveen's ProKidney position peaked at $2.36M in Q2 2023.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.